Obio Technology (Shanghai) Corp., Ltd. (SHA:688238)
China flag China · Delayed Price · Currency is CNY
6.03
-0.19 (-3.05%)
At close: Jun 13, 2025, 2:57 PM CST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018
Gene Therapy Contract Development and Manufacturing Organization
106.99M
Log In
Log In
Log In
Log In
Upgrade
Gene Therapy Contract Development and Manufacturing Organization Growth
-50.64%
Log In
Log In
Log In
Log In
Upgrade
Gene Therapy Contract Research Organization
79.45M
Log In
Log In
Log In
Log In
Upgrade
Gene Therapy Contract Research Organization Growth
20.56%
Log In
Log In
Log In
Log In
Upgrade
Biological Agents, Reagents and Others
18.37M
Log In
Log In
Log In
Log In
Upgrade
Biological Agents, Reagents and Others Growth
176.90%
Log In
Log In
Log In
Log In
Upgrade
Other
-
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade
Biomedicine
-
Log In
Log In
Log In
Log In
Upgrade
IND-CMC service
-
Log In
Log In
Log In
Log In
Upgrade
IND-CMC service Growth
-
Log In
Log In
Log In
Log In
Upgrade
Clinical Phase I & II Manufacturing Services
-
Log In
Log In
Log In
Log In
Upgrade
Pre-IND Supporting Services
-
Log In
Log In
Log In
Log In
Upgrade
Pre-IND Supporting Services Growth
-
Log In
Log In
Log In
Log In
Upgrade
Non-IND Services
-
Log In
Log In
Log In
Log In
Upgrade
Non-IND Services Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018
China
204.49M
Log In
Log In
Log In
Log In
Upgrade
China Growth
-29.54%
Log In
Log In
Log In
Log In
Upgrade
Overseas
315.05K
Log In
Log In
Log In
Log In
Upgrade
Overseas Growth
-70.90%
Log In
Log In
Log In
Log In
Upgrade